The Value of Diagnostic Information in Acute Respiratory infections – Observations from the COVID-19 pandemic
The Value of Diagnostic Information in Acute Respiratory infections – Observations from the COVID-19 pandemic
The COVID-19 pandemic has exposed governments and healthcare systems to unprecedented challenges, facing the surge of a novel, highly contagious virus that can potentially cause fatal forms of acute respiratory infections. With global public health at stake, policymakers were looking for solutions to tackle this situation as fast as possible and came to appreciate the significant value of information at hand gained from In vitro Diagnostics (IVDs).
During the pandemic, IVDs have offered a wide spectrum of information that helps to control the spread of SARS-CoV-2 in the population and improve the management of patients with acute respiratory tract infections:
- Information gained from IVD testing contributes to slowing down or even breaking the transmission chains of SARS-CoV-2 and consequently preventing COVID-19 diseases.
- Diagnostic information facilitates optimal disease management for patients with acute respiratory tract infections, not only stemming from SARS-CoV-2 but also from other co-circulating infection agents such as influenza viruses.
By carving out the value of diagnostic information in acute respiratory infections against the background of the COVID-19 pandemic, this case study highlights the need for appropriate policy actions to unlock the full potential of diagnostic information – in times of public health crises but also beyond.
Author: MedTech Europe
Read more:
